The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,831.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,831.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Croda acquires fragrance business Parfex

7 Apr 2021 07:00

RNS Number : 5770U
Croda International PLC
07 April 2021
 

Croda expands Iberchem's fragrances offering with the acquisition of Parfex

 

7 April 2021

 

Croda International Plc ("Croda") today announces that its fragrances and flavours subsidiary, Iberchem, has agreed to acquire Parfex S.A. ("Parfex"), a fine fragrance business based in Grasse, France, for a total enterprise value of €45 million.

 

Established in 1985 and now employing 75 people, Parfex creates fragrances principally for premium personal care and fine perfumery markets, leveraging the natural raw materials that are available in the region. The business has seen good growth over the last decade, generating €3.6m EBITDA in 2020, and now sells its fragrances in more than 50 countries worldwide.

 

Parfex is 82% owned by its founders with the remaining free float of shares listed on the Euronext Access market. Croda has agreed to acquire 93% of Parfex's outstanding shares, comprising the founding shareholders and certain minority investors. Croda ultimately expects to acquire 100% of the total outstanding share capital, subject to a potential tender offer and subsequent de-listing.

 

Steve Foots, Croda Chief Executive Officer, said:

 

"We believe that transitioning to more natural raw materials is a potential differentiator in the fragrance market. Parfex will play an important role in Iberchem's plans to increase its sustainable fragrance offerings and further enhances our position in the creation of higher-value fine fragrances."

 

The transaction is subject to customary pre closing conditions and is expected to close by the end of the second quarter of 2021.

 

For more information, please contact:

 

Investors: David Bishop, Croda +44 7823 874428

Media: Charlie Armitstead, Teneo +44 7703 330269

 

About Croda - www.croda.com

 

Established in 1925, Croda is the name behind sustainable, high performance ingredients and technologies in some of the world's most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere.

 

Croda is a FTSE 100 company with over 5,600 passionate and innovative employees, working across manufacturing sites and offices around the world with a shared Purpose to use Smart Science to Improve Lives™. As part of this Purpose, and with around two thirds of its organic raw materials already from bio-based sources, Croda has committed to be the most sustainable supplier of innovative ingredients, becoming Climate, Land and People Positive by 2030.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAKLKEDAFEFA
Date   Source Headline
6th Mar 201910:01 amRNSDirector/PDMR Shareholding
6th Mar 201910:01 amRNSDirector/PDMR Shareholding
6th Mar 201910:00 amRNSDirector/PDMR Shareholding
6th Mar 20199:58 amRNSDirector/PDMR Shareholding
6th Mar 20199:57 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSResults for the year ended 31 December 2018
12th Feb 20194:47 pmRNSDirector/PDMR Shareholding
11th Jan 20194:21 pmRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSAcquisition completion
17th Dec 20187:00 amRNSAcquisition of global vaccine adjuvant specialist
12th Dec 20181:14 pmRNSDirector/PDMR Shareholding
22nd Nov 20181:54 pmRNSDirector Declaration
22nd Nov 20188:07 amRNSDirector/PDMR Shareholding
14th Nov 20182:48 pmRNSDirector/PDMR Shareholding
14th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTrading Update for the Third Quarter 2018
26th Oct 20187:00 amRNSAcquisition update
12th Oct 20181:42 pmRNSDirector/PDMR Shareholding
4th Oct 20183:03 pmRNSDirector/PDMR Shareholding
4th Oct 20183:01 pmRNSDirector/PDMR Shareholding
28th Sep 20183:35 pmRNSDirector/PDMR Shareholding
11th Sep 20184:50 pmRNSDirector/PDMR Shareholding
6th Sep 20184:07 pmRNSDirector/PDMR Shareholding
5th Sep 20187:00 amRNSAppointment of Broker
22nd Aug 201811:06 amRNSDirector Declaration
13th Aug 20184:37 pmRNSDirector/PDMR Shareholding
7th Aug 20189:11 amRNSDirector/PDMR Shareholding
31st Jul 20184:16 pmRNSDirector/PDMR Shareholding
25th Jul 20184:19 pmRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20182:27 pmRNSDirector/PDMR Shareholding
21st Jun 20187:00 amRNSDirector/PDMR Shareholding
12th Jun 20184:04 pmRNSDirector/PDMR Shareholding
11th Jun 20182:02 pmRNSDirector/PDMR Shareholding
31st May 20183:41 pmRNSDirector/PDMR Shareholding
25th May 20182:09 pmRNSDirector/PDMR Shareholding
11th May 20184:31 pmRNSDirector/PDMR Shareholding
26th Apr 20183:57 pmRNSDirector/PDMR Shareholding
26th Apr 20189:16 amRNSResult of AGM
25th Apr 20187:00 amRNSTrading Update for the First Quarter 2018
20th Apr 201811:14 amRNSDirectorate Change
20th Apr 20187:00 amRNSDirectorate Change
19th Apr 20189:47 amRNSDirector/PDMR Shareholding
19th Apr 20189:44 amRNSDirector/PDMR Shareholding
11th Apr 20181:09 pmRNSDirector/PDMR Shareholding
11th Apr 20187:00 amRNSCapital Markets Event
3rd Apr 20182:19 pmRNSDirector/PDMR Shareholding
28th Mar 20182:39 pmRNSDirector/PDMR Shareholding
28th Mar 20182:38 pmRNSDirector/PDMR Shareholding
28th Mar 201812:19 pmRNSScheme of Arrangement becomes Effective

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.